AAIC 2025 Abstract·23 DecPharmacokinetic characterization of buntanetap in plasma of patients with early Alzheimer’s and Parkinson’s diseasesTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecA dual 6‐month (stage 1) & 18‐month (stage 2) prospective, randomized, placebo‐controlled, double‐blind, pivotal clinical trial investigating efficacy and safety of buntanetap in early Alzheimer's patientsTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecAdvancing Buntanetap: Comparative Pharmacokinetic Characterization of the Original Semi‐Crystalline with the Novel Crystalline Form in Animals and HumansTrial in peopleInterventionsPaper